Alright, let’s talk plateaus — because I keep getting this question nonstop.
If you’ve been on sema or tirz and the scale just… stopped moving… you’re not alone. And you’re not “doing it wrong.” This is biology.
Why we plateau…
When you lose weight, your body notices and fights back. Metabolism slows, hunger signals shift, and your body gets more efficient with calories. That’s metabolic adaptation — and it’s why a lot of people eventually stall (often around the 14–15 month mark on sema).
What makes retatrutide different?
Sema = GLP-1
Tirz = GLP-1 + GIP
Retatrutide = GLP-1 + GIP + Glucagon
That third receptor (glucagon) is the potential game-changer.
In phase 2 data, people on the 12mg dose lost ~24.2% of body weight over 48 weeks, and what’s crazy is the weight-loss curve kept dropping — researchers noted a plateau hadn’t been reached yet.
What glucagon is doing (in plain English)?
Glucagon activity can help:
- Increase energy expenditure (more burn at rest, not just less appetite)
- Boost fat oxidation (more “use stored fat for fuel” signaling)
- Increase thermogenesis (more heat production = more calories burned)
- Reduce liver fat significantly (reported as high as ~82% at higher doses)
Why this may help prevent plateaus?
If you only reduce appetite, your body can adapt by slowing the engine down to match.
With glucagon in the mix, you’re lowering intake and pushing burn up — which is basically fighting metabolic adaptation in real time.
GLP-1 = appetite control
GIP = nutrient handling / metabolic support
Glucagon = keeps the metabolic “engine” running hotter
Lifestyle still matters (non-negotiable)
No matter what you’re using — sema, tirz, or reta — your results will hinge on:
- Lift weights (2–3x/week minimum to protect muscle)
- Protein first (low protein = muscle loss = slower metabolism)
- Sleep (7–9 hours; poor sleep can stall you fast)
- Stress management (chronic cortisol = stubborn fat storage)
- Cardio as a tool, not the king (zone 2 helps; don’t overdo it)
Bottom line
Plateaus aren’t a moral failing — they’re your body doing what it was designed to do: survive.
Retatrutide’s triple agonist approach (especially the glucagon piece) is one of the most interesting “anti-plateau” mechanisms we’ve seen so far. But it’s still a tool — and the best results come when you stack it with the fundamentals.
Questions? Drop them below 👇
Educational content about research compounds. Not medical advice. Always work with a qualified healthcare professional for medical decisions.